Skip to main content
Fig. 1 | Chinese Medicine

Fig. 1

From: Cordyceps sinensis relieves non-small cell lung cancer by inhibiting the MAPK pathway

Fig. 1

Cordyceps sinensis inhibited lung cancer in mice with NSCLC. A Fluorescence photographs of mice were obtained 2 weeks after administration (n = 3; **P < 0.01 and ***P < 0.001 versus the model; &P < 0.05, vs. PD1). B Body weight for mice in the different treatment groups (n = 6). C Microscopic morphology of the lung tumor tissues in each group (HE, 20×). a Control group (Ctrl); b Model group (Model); c C. sinensis group (5 g/kg, BH); d 2 mg/kg PD1 inhibitor group (PD1); e 2 mg/kg PD1 inhibitor + 1 g/kg C. sinensis group (PD1 + BL); f 2 mg/kg PD1 inhibitor + 5 g/kg C. sinensis group (PD1 + BH).

Back to article page